Heparin: Thrombocytopenia in patients on dialysis: 3 case reportsBlood-dyscrasias, drug-inducedHeparin, adverse reactionsReactions Weekly
In 6 patients on continuous ambulatory peritoneal dialysis we investigated the inhibition of intraperitoneal fibrin formation by heparin. A continuous addition of 500 U of heparin per liter dialysate was used for 52 h. In plasma no heparin activity could be detected, even 52 h after intraperitoneal...
Background: Heparin-free dialysis (HFD), i.e. only priming of the dialyser and no systemic heparinization, might reduce the risk of bleeding in dialysis patients receiving oral anticoagulation. The efficacy of HFD with two different membranes [polyacrylonitrile (AN69ST) vs. polysulphone (FX100)...
BACKGROUND: , universally used in patients on dialysis, is the cause for immune-mediated (HIT).: From an HIT registry, six patients were identified who received recent solely for dialysis, developed HIT, and were treated with . Platelets counts, aPTTs, dosing, and outcomes were assessed.: ...
7) the advantages of low molecular weight heparin can be found in many textbooks and will not be repeated. My family is associated with renal transplantation in dialysis patients with dialysis room. Kidney transplantation. The patients general economic situation we can also maintain the level of ...
Objective To investigate the effect of low molecular weight heparin on lipid parameters in hemodialysis patients. Methods The trial was double blind, open, controlled and randomized for one year. 35 pre-dialysis patients were divided into two groups: UFH(unfractionated heparin) group(n = 13) and...
To compare the outcome of two groups of 16 patients with hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome treated with heparin therapy or treated conservatively in the postpartum period. STUDY DESIGN: This is a retrospective cohort study comparing 16 consecutive patients with HELL...
BackgroundPulmonary embolism (PE) occurs in 50% or more of patients with proximal deep-vein thrombosis. Low-molecular-weight heparin treatment is
Heparin is also used as an anticoagulant in extra-corporeal circuits such as in cardiopulmonary bypass and renal dialysis. Pentasaccharide (comprising the five sugar moieties in heparin that mediate its anticoagulant activity) may soon replace heparin and LMWH in some of these indications. Heparin ...
None - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 被引量: 81发表: 1994年 Nutritional Markers and Survival in Maintenance Dialysis Patients Background. A recent survey puts the global dialysis population at ...